GH
Price
$106.00
Change
+$2.13 (+2.05%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
13.67B
77 days until earnings call
Intraday BUY SELL Signals
MYNZ
Price
$1.16
Change
-$0.00 (-0.00%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
9.66M
131 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GH vs MYNZ

Header iconGH vs MYNZ Comparison
Open Charts GH vs MYNZBanner chart's image
Guardant Health
Price$106.00
Change+$2.13 (+2.05%)
Volume$50K
Capitalization13.67B
Mainz Biomed
Price$1.16
Change-$0.00 (-0.00%)
Volume$570
Capitalization9.66M
GH vs MYNZ Comparison Chart in %
GH
Daily Signal:
Gain/Loss:
MYNZ
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GH vs. MYNZ commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GH is a StrongBuy and MYNZ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (GH: $103.87 vs. MYNZ: $1.17)
Brand notoriety: GH: Notable vs. MYNZ: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GH: 22% vs. MYNZ: 14%
Market capitalization -- GH: $13.67B vs. MYNZ: $9.66M
GH [@Medical Specialties] is valued at $13.67B. MYNZ’s [@Medical Specialties] market capitalization is $9.66M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $12.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GH’s FA Score shows that 0 FA rating(s) are green whileMYNZ’s FA Score has 0 green FA rating(s).

  • GH’s FA Score: 0 green, 5 red.
  • MYNZ’s FA Score: 0 green, 5 red.
According to our system of comparison, both GH and MYNZ are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GH’s TA Score shows that 4 TA indicator(s) are bullish while MYNZ’s TA Score has 4 bullish TA indicator(s).

  • GH’s TA Score: 4 bullish, 4 bearish.
  • MYNZ’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MYNZ is a better buy in the short-term than GH.

Price Growth

GH (@Medical Specialties) experienced а -4.54% price change this week, while MYNZ (@Medical Specialties) price change was +17.01% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.29%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was +28.81%.

Reported Earning Dates

GH is expected to report earnings on Feb 19, 2026.

MYNZ is expected to report earnings on Apr 14, 2026.

Industries' Descriptions

@Medical Specialties (-0.29% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GH($13.7B) has a higher market cap than MYNZ($9.66M). GH YTD gains are higher at: 240.000 vs. MYNZ (-72.917). MYNZ has higher annual earnings (EBITDA): -20.22M vs. GH (-368.35M). GH has more cash in the bank: 629M vs. MYNZ (978K). MYNZ has less debt than GH: MYNZ (8.27M) vs GH (1.33B). GH has higher revenues than MYNZ: GH (829M) vs MYNZ (917K).
GHMYNZGH / MYNZ
Capitalization13.7B9.66M141,866%
EBITDA-368.35M-20.22M1,822%
Gain YTD240.000-72.917-329%
P/E RatioN/AN/A-
Revenue829M917K90,403%
Total Cash629M978K64,315%
Total Debt1.33B8.27M16,131%
FUNDAMENTALS RATINGS
GH: Fundamental Ratings
GH
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GHMYNZ
RSI
ODDS (%)
Bearish Trend 6 days ago
82%
Bullish Trend 6 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
79%
Bullish Trend 6 days ago
89%
Momentum
ODDS (%)
Bullish Trend 6 days ago
79%
Bearish Trend 6 days ago
90%
MACD
ODDS (%)
Bullish Trend 6 days ago
86%
Bearish Trend 6 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 6 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
79%
Bearish Trend 6 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
85%
Bullish Trend 6 days ago
90%
Aroon
ODDS (%)
Bullish Trend 6 days ago
79%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GH
Daily Signal:
Gain/Loss:
MYNZ
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HFFG2.500.07
+2.88%
HF Foods Group
CTKB5.410.08
+1.50%
Cytek Biosciences
CNS61.830.16
+0.26%
Cohen & Steers
BFRI0.81N/A
-0.11%
Biofrontera
PBA38.52-0.45
-1.15%
PEMBINA PIPELINE Corp

GH and

Correlation & Price change

A.I.dvisor indicates that over the last year, GH has been loosely correlated with NTRA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if GH jumps, then NTRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GH
1D Price
Change %
GH100%
-1.28%
NTRA - GH
54%
Loosely correlated
+0.96%
RGEN - GH
42%
Loosely correlated
-0.81%
VCYT - GH
41%
Loosely correlated
-0.43%
TWST - GH
41%
Loosely correlated
-0.60%
GKOS - GH
40%
Loosely correlated
-0.07%
More

MYNZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, MYNZ has been loosely correlated with ACRS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MYNZ jumps, then ACRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYNZ
1D Price
Change %
MYNZ100%
+3.54%
ACRS - MYNZ
41%
Loosely correlated
+3.64%
STXS - MYNZ
27%
Poorly correlated
-3.42%
GH - MYNZ
24%
Poorly correlated
-1.28%
BLFS - MYNZ
23%
Poorly correlated
-0.12%
BNGO - MYNZ
23%
Poorly correlated
-2.33%
More